Cyberonics Inc.
Cyberonics Building
100 Cyberonics Boulevard
Houston,
TX 77058-2072
United States - Map
Phone: 281-228-7200
Fax: 281-218-9332
Web Site: http://www.cyberonics.com
| Cyberonics, Inc., a neuromodulation company, engages in the design, development, manufacture, sale, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of refractory epilepsy and treatment-resistant depression. Its VNS therapy system consists of a pulse generator to provide the stimulation to the vagus nerve; a bipolar lead; a tunneling tool to assist with implantation surgery; a programming wand and software for setting the stimulation parameters after implantation of the generator and lead; magnets to suspend or induce stimulation manually; and instruction manuals. The company sells its products for refractory epilepsy through direct sales and marketing forces in Austria, Belgium, Denmark, France, Germany, Luxemburg, the Netherlands, Norway, Spain, Sweden, Switzerland, and the United Kingdom, as well as through distribution agreements with independent distributors of various territories, including Canada, Mexico, Australia, parts of Central and South America, Asia, the Middle East, and Europe. Cyberonics, Inc. was founded in 1987 and is headquartered in Houston, Texas. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Daniel J. Moore , 48
Chief Exec. Officer, Pres and Exec. Director |
$
899.00K |
$
0 | Mr. Reese S. Terry Jr., 67
Co-Founder, Director and Member of Nominating & Governance Committee |
N/A
| N/A | Mr. Gregory H. Browne , 56
Chief Financial Officer, Principal Accounting Officer and VP of Fin. |
$
449.00K |
$
0 | Mr. Randal L. Simpson , 49
VP of Operations, R&D |
$
388.00K |
$
0 | Mr. David S. Wise , 53
VP, Sec. and Gen. Counsel |
$
413.00K |
$
0 |
|
|
|
Dollar amounts are as of
31-Dec-09
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.22% Nasdaq 
Profile
